2.Superantigen and class II MHC molecules.
Journal of Korean Medical Science 1995;10(6):393-398
No anstract available.
Animal
;
Binding Sites
;
Histocompatibility Antigens Class II/chemistry/immunology/*metabolism
;
Human
;
Superantigens/chemistry/immunology/*metabolism
3.Immunosuppression by T regulatory cells in cows infected with Staphylococcal superantigen.
Byoung Sun CHANG ; Gregory A BOHACH ; Sang Un LEE ; William C DAVIS ; Lawrence K FOX ; Witold A FERENS ; Keun Seok SEO ; Hye Cheong KOO ; Nam Hoon KWON ; Yong Ho PARK
Journal of Veterinary Science 2005;6(3):247-250
Our recent study has provided that the in vitro SEC-induced proliferation of bovine T cells is preceded by a period of a non-proliferative immunoregulation of T cells that may be associated with cytokine production regulated by type 1 or type 2 T cells. Inversion of CD4+:CD8+ T cell ratio and induction of CD8+T cells with immunoregulatory activity could increase the probability of intracellular survival of Staphylococcus aureus (S. aureus). The increase of activated CD8+(ACT2+ BoCD8+) T cells in cows with mastitis caused by S. aureus may be associated with immune-regulatory function in the bovine mammary gland. The difference and similarity between bovine activated CD8+ T cells (CD8+ CD26+)and well-established human CD4+ CD25+ T regulatory (Tr)cells may help to reveal their unique immune regulatory system in the host infected with S. aureus.
Animals
;
Cattle
;
Cell Proliferation
;
Female
;
Lymphocyte Activation/immunology
;
Mastitis, Bovine/*immunology/microbiology
;
Staphylococcal Infections/immunology/*veterinary
;
Staphylococcus/*immunology
;
*Superantigens
;
T-Lymphocytes/*immunology
4.Enhancement of immune responses to hepatitis B DNA vaccine by superantigen SEA in mice.
Yan-Wen JIN ; Ping LI ; Quan-Bin XU ; Xuan LIU ; Wei HUANG ; Yun-Long WANG ; Cheng CAO ; Qing-Jun MA
Chinese Journal of Biotechnology 2005;21(5):681-685
To investigate the adjuvant effect of plasmid DNA encoding superantigen SEA (D227A) (pmSEA) on immune responses induced by HBV DNA vaccine containing HBV preS2 and S antigen in BABL/c (H-2d). BALB/c mice were immunized intramuscular injection with HBV DNA vaccine (pHBVS2S) mixed with or without pmSEA plasmid. Antibodies againat HBV PreS2 and S antigen in the sera were accessed by Anti-HBs ELISA, and the HBsAg specific cytotoxic T lymphocytes (CTLs) activity was determined by 5 Chromium Release Assay. The HBs peptide-specific IFN-gamma secreting T cells were detected by ELISPOT. Anti-HBs antibody titers and CTLs activity in mice immunized with pmSEA + pHBVS2S group were significant higher (P < 0.05) than pHBVS2S DNA vaccine group. The ratio of IgG1/IgG2a (0.282) was apparently different from the group immunized with peptide (10). Mice immunized with HBV DNA vaccine plus adjuvant produce higher titer of IgG1 and IgG2a antibodies against HBV S antigen 1.36 and 1.73 time higher than that without adjuvant respectively. HBs peptide--specific IFN-gamma secreting T cells increased 2 - 3 times by the pmSEA adjuvant, compared to DNA vaccine group. HBV DNA vaccine (pHBVS2S) induces humoral and cellular immuno-responses in BALB/c mice, and the responses could be significantly boasted by the plasmid encoding mSEA. Therefore the pmSEA was a potential adjuvant for DNA vaccines.
Adjuvants, Immunologic
;
Animals
;
Enterotoxins
;
immunology
;
Hepatitis B
;
immunology
;
prevention & control
;
therapy
;
Hepatitis B Antibodies
;
blood
;
Hepatitis B Vaccines
;
immunology
;
Interferon-gamma
;
secretion
;
Mice
;
Mice, Inbred BALB C
;
Staphylococcus aureus
;
immunology
;
Superantigens
;
immunology
;
T-Lymphocytes, Cytotoxic
;
immunology
;
Vaccination
;
Vaccines, DNA
;
immunology
5.Inhibiting tumor-cell growth by novel truncated staphylococcal enterotoxin C2 mutant.
Jing HUI ; Fang XIAO ; Hui LI ; Xiaojin CUI ; Hongsheng LIU ; Fengqing HU
Chinese Journal of Biotechnology 2011;27(6):891-899
Clinical application of staphylococcal enterotoxin C2 (SEC2) was restricted during the cure of malignant tumor due to its side-effects. The aim of this study was to obtain SEC2 mutant, preserving the important functional sites responsible for the T-cell stimulatory activities but removing the sites responsible for emetic activity, through truncation of SEC2. It would efficiently solve the question of SEC2 side-effect. According to the results of methyl thiazol tetrazolium (MTT) assay in vitro, novel truncated SEC2 mutant (NSM) efficiently stimulated T-cell proliferation and inhibited the growth of such tumor cells as human colorectal cancer cells (Cx-1) and human breast cancer cells (MCF-7) in vitro. Activities of T cell stimulating and anti-tumor of NSM were similar to those of SEC2. According to results of animal experiments, the mutant no longer induced emetic response even if the dose was a 10-fold excess of the amount of SEC2 required. And also, NSM obviously inhibited the tumor growth in tumor-bearing mice. Therefore, we obtained novel truncated staphylococcal enterotoxin C2 mutant, which could efficiently inhibit the growth of tumor cells. It will become novel anti-tumor agents with the lowest side-effects and best treatment effects in clinic.
Animals
;
Antineoplastic Agents
;
adverse effects
;
pharmacology
;
Breast Neoplasms
;
immunology
;
pathology
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Colorectal Neoplasms
;
immunology
;
pathology
;
Enterotoxins
;
genetics
;
immunology
;
Humans
;
Mice
;
Mutant Proteins
;
immunology
;
Staphylococcus aureus
;
immunology
;
Superantigens
;
immunology
;
T-Lymphocytes
;
immunology
;
Vomiting
;
prevention & control
6.Culture of dendritic cells in vitro and its anti-tumor immunotherapy.
Changyun MA ; Fang WU ; Fanyi KONG ; Yanwen ZHOU
Chinese Journal of Lung Cancer 2010;13(5):483-487
BACKGROUND AND OBJECTIVEImmunocompromised patients with malignant tumor always lack of strong anti-tumor immune response, because the antigenicity of tumor cells is weak, and antigen-presenting cell function is low, so that can not be effectively presenting tumor antigens to the lymphocytes. Therefore, how to effectively induce anti-tumor immune response is the key issue. Through the study on establishing a method to culture dendritic cells (DC) in vitro and to observe the anti-lung cancer immunological effect induced by DC, we provided definite experiment basis for the clinic application of vaccine based on DC.
METHODSThrough the experiment we get the soluble antigen polypeptide from lung cancer cells GLC-82 by 3 mol/L potassium chloride. DCs are cultured and obtained from peripheral blood mononuclear cell by GM-CSF, IL-4 and TNF-a. DCs are identified by flow cytometer (FCM) and immunostaining. DCs modified by lung cancer tumor soluble antigen (TSA) and staphylococcal enterotox in A (SEA), DCs modified by TSA or DCs modified by SEA or DCs modified by nothing were cultivated together with T lymphocyte, and the obtained cells are named TSA-SEA-DCL or TSA-DCL or SEA-DCL or DCL as effector cells. The anti-tumor activity of every effector cells against target cells was assayed with MT method. Shape of DCs and effector cells, and the process of killing target cells were observed in microscope.
RESULTSInduced DCs expressed more CD1a, CD80 and HLA-DR, which had typical cell traits such as tree branch. The killing ratio of the TSA-SEA-DCL in vitro to GLC-82 is larger than TSA-DCL, SEA-DCL and DCL, also larger than to K562. When the effector cells cultivate with target cells, we can observe the CTL approach and gather to the cancer cell, induce it necrosis and apoptosis.
CONCLUSIONRipe DCs that have typical characteristic and phenotype could be induced successfully. High potency and relatively specific antilung caner effect can be prepared in virtue ofDC Bacterin Induced by lung caner TSA and SEA.
Antigens, Neoplasm ; immunology ; Cells, Cultured ; Dendritic Cells ; cytology ; immunology ; Enterotoxins ; immunology ; Granulocyte-Macrophage Colony-Stimulating Factor ; pharmacology ; Humans ; Immunotherapy ; Interleukin-4 ; pharmacology ; Lung Neoplasms ; immunology ; therapy ; Superantigens ; immunology ; T-Lymphocytes, Cytotoxic ; immunology
7.Effect and mechanism of superantigen staphylococcal enterotoxin therapy for mouse gastric tumor.
Journal of Huazhong University of Science and Technology (Medical Sciences) 2003;23(2):161-162
The anti-tumor effect and mechanism of the staphylococcal enterotoxin A (SEA) were studied. The mouse gastric tumor model was produced by subcutaneously inoculating gastric tumor cells (MGC80-3). The experimental group was treated with SEA, and the control group was treated with normal saline. The percentage of tumor generation and tumor mass was measured. The results showed that the percentage of the tumor generation in the SEA-treated mice was lower than in the control group, but there was no significant difference (P > 0.05). However, the tumor mass in the experimental group was significantly lighter than in the control group, with the difference being very significant (P < 0.001). There were more CD4+ T cells and CD8+ T cells in the tumor of the mice treated with SEA than those of the control group. SEA has an obvious anti-tumor effect on mice gastric tumor. The mechanism might be that SEA induces the effect of superantigen-dependent cell mediated cytotoxicity to the tumor cells.
Adjuvants, Immunologic
;
pharmacology
;
Animals
;
Antineoplastic Agents
;
pharmacology
;
CD4-Positive T-Lymphocytes
;
immunology
;
CD8-Positive T-Lymphocytes
;
immunology
;
Enterotoxins
;
immunology
;
pharmacology
;
Female
;
Mice
;
Mice, Inbred BALB C
;
Neoplasm Transplantation
;
Random Allocation
;
Staphylococcus aureus
;
immunology
;
Stomach Neoplasms
;
immunology
;
pathology
;
Superantigens
;
immunology
;
pharmacology
8.Local cellular immune response induced by ultrasound-guided tumor bed superantigen injection after percutaneous microwave coagulation therapy for liver cancer.
Xiu-jie HAN ; Bao-wei DONG ; Ping LIANG ; Xiao-ling YU ; De-jiang YU
Chinese Journal of Oncology 2009;31(8):602-606
OBJECTIVETo investigate the local cellular immune response after injection of superantigen, the highly agglutinative staphylococin (HAS), into the tumor bed after ultrasound-guided percutaneous microwave coagulation therapy (PMCT) in the liver cancer patients.
METHODSNinety-two patients with pathologically proven primary liver cancer were divided into two groups: 45 in group A were treated by PMCT alone and 47 in the group B by combined with ultrasound-guided percutaneous injection of highly agglutinative staphylococin (HAS). Before and after PMCT and HAS treatment, the patients underwent ultrasound-guided percutaneous biopsy from the tumor bed and the samples were examined by pathology and immunohistochemistry. The infiltration of CD3+, CD4+, CD57+ and CD68+ lymphocytes in treatment zone was compared between the two groups. Moreover, the infiltrating immunocytes were observed by transmission electron microscopy.
RESULTSOne week after HAS injection, the densities of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 54.50 +/- 18.44, 38.14 +/- 12.44, 33.38 +/- 10.79 and 45.56 +/- 16.53, respectively. All the above mentioned parameters increased significantly in varying degrees compared with that before PMCT or HAS injection (P < 0.05). Four weeks after HAS injection, the density of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 32.67 +/- 10.42, 23.43 +/- 6.99, 18.63 +/- 7.89 and 30.01 +/- 11.05, respectively, still significantly higher than those before PMCT (P < 0.05). Five weeks after PMCT and HAS injection, the densities of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 54.50 +/- 18.44, 38.14 +/- 12.44, 33.38 +/- 10.79 and 45.56 +/- 16.53, versus 32.03 +/- 8.11, 15.67 +/- 8.32, 15.23 +/- 8.26 and 29.67 +/- 11.98 in the group A, respectively, still with a significant difference between the two groups (P < 0.05). A lot of lysosomes, endoplasmic reticulum and mitochondria in the immune cells after injection of HAS were observed by transmission electron microscopy.
CONCLUSIONThe local cellular immunity in liver cancer treatment area can be significantly improved by ultrasound-guided injection of highly agglutinative staphylococin after percutaneous microwave coagulation therapy.
Adult ; Aged ; Antigens, CD ; immunology ; Antigens, Differentiation, Myelomonocytic ; immunology ; CD3 Complex ; immunology ; CD4 Antigens ; immunology ; CD57 Antigens ; immunology ; Electrocoagulation ; methods ; Female ; Humans ; Liver Neoplasms ; pathology ; therapy ; Male ; Microwaves ; therapeutic use ; Middle Aged ; Superantigens ; therapeutic use ; T-Lymphocytes ; immunology
9.Production and Characterization of Anti-Staphylococcal Toxic Shock Syndrome Toxin-1 Monoclonal Antibody.
Jeong Su PARK ; Jae Seok KIM ; Jongyoun YI ; Eui Chong KIM
The Korean Journal of Laboratory Medicine 2008;28(6):449-456
BACKGROUND: Recently the association between the virulence factors of Staphylococcus aureus and the outcome of the patients infected with the organism appears to be the subject of active investigation. Toxic shock syndrome toxin-1 (TSST-1) is thought to be a clinically more significant virulence factor than other staphylococcal toxins. We attempted to produce and characterize monoclonal antibodies to staphylococcal TSST-1. METHODS: An important epitope of TSST-1, amino acids 1-15 region, was synthesized into a peptide antigen, and Balb/c mice were immunized by intraperitoneal injection of the synthetic antigen. Hybridomas were produced by fusing immunized murine splenocytes with immortal myeloma cells. Hybridomas were cloned through a limiting dilution method. Stable cultured hybridoma was injected into the peritoneal cavity of Balb/c mice, and peritoneal fluid containing the monoclonal antibody was produced. RESULTS: One IgG2b type monoclonal antibody and two IgM type monoclonal antibodies were obtained. The IgG2b type monoclonal antibody was able to detect 5 microgram of TSST-1 with Western blot analysis and showed a strong reactivity to TSST-1 with ELISA. CONCLUSIONS: Highly immunoreactive anti-TSST-1 monoclonal antibody was produced by the use of synthesized peptide antigen. Diagnostic and protective capacity of this monoclonal antibody should be evaluated in the future.
Amino Acid Sequence
;
Animals
;
Antibodies, Monoclonal/biosynthesis/*immunology/isolation & purification
;
Bacterial Toxins/*immunology
;
Blotting, Western
;
Enterotoxins/*immunology
;
Enzyme-Linked Immunosorbent Assay
;
Hybridomas/metabolism
;
Mice
;
Molecular Sequence Data
;
Peptides/chemical synthesis/pharmacology
;
Superantigens/*immunology
10.Enhanced SEC2 mutants and their superantigen activities.
Guojun ZHANG ; Mingkai XU ; Jian SUN ; Hongyi LI ; Hongli YANG ; Huiwen ZHANG ; Chenggang ZHANG
Chinese Journal of Biotechnology 2013;29(6):803-813
As a superantigen protein, Staphylococcal enterotoxin C2 (SEC2) activates the immune system effectively even in extremely low concentrations, and this property could be applied in adjuvant therapy against tumors and infectious diseases. In order to enhance the superantigen activity of SEC2, the residues at position 102-106 of native SEC2 were substituted for WWH, WWT and WWP by over-lap PCR, and three mutants named ST-1, ST-2 and ST-3 were obtained. Stimulating activity to murine lymphocytes proliferation and inhibiting activity to tumor cell growth of the three mutants were significantly improved compared with the native SEC2. Febrile activities of ST-1 and ST-3 were comparable with the native SEC2, but ST-2 showed markedly increased febrile activity than native SEC2. Moreover, the levels of IL-2, IFN-gamma and TNF-alpha secreted by T cells stimulated with the three mutants were significantly improved, which might be the possible reason for enhanced tumor cell growth inhibition activities. Furthermore, mVbeta8.2 gene transcription levels of murine splenocytes stimulated by the three mutants were dramatically increased compared with native SEC2, suggesting their increased affinities to TCR mVbeta8.2 molecular, which might be the main reason for their enhanced superantigen activities.
Animals
;
Enterotoxins
;
genetics
;
immunology
;
Female
;
Interferon-gamma
;
secretion
;
Interleukin-2
;
secretion
;
Lymphocyte Activation
;
Mice
;
Mice, Inbred BALB C
;
Mutant Proteins
;
genetics
;
immunology
;
Receptors, Antigen, T-Cell
;
immunology
;
Superantigens
;
genetics
;
immunology
;
Tumor Necrosis Factor-alpha
;
secretion